Search Results

Filter
  • 1-10 of  49 results for ""Graft vs Tumor Effect""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2 + Murine Neuroblastoma.

  • Authors : Bates PD; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.; Rakhmilevich AL

Subjects: Graft vs Tumor Effect* ; Hematopoietic Stem Cell Transplantation* ; Immunotherapy, Adoptive*

  • Source: Frontiers in immunology [Front Immunol] 2021 Aug 19; Vol. 12, pp. 668307. Date of Electronic Publication: 2021 Aug 19 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells.

  • Authors : Baker FL; Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston, Houston, TX, United States.; Department of Nutritional Sciences, University of Arizona, Tucson, AZ, United States.

Subjects: Hematopoietic Stem Cell Transplantation*; Exercise/Exercise/Exercise/*physiology ; Graft vs Tumor Effect/Graft vs Tumor Effect/Graft vs Tumor Effect/*immunology

  • Source: Frontiers in immunology [Front Immunol] 2020 Jan 24; Vol. 10, pp. 3082. Date of Electronic Publication: 2020 Jan 24 (Print Publication: 2019).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review.

  • Authors : Anwer F; Department of Medicine, Hematology & Oncology, University of Arizona, Tucson, AZ, USA.; Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.

Subjects: Hematopoietic Stem Cell Transplantation*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*immunology ; Graft vs Tumor Effect/Graft vs Tumor Effect/Graft vs Tumor Effect/*immunology

  • Source: Immunotherapy [Immunotherapy] 2017 Jan; Vol. 9 (2), pp. 123-130.Publisher: Future Medicine Country of Publication: England NLM ID: 101485158 Publication Model: Print Cited Medium: Internet ISSN: 1750-7448

Record details

×
Academic Journal

Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation.

  • Authors : Hoogendoorn M; Department of Hematology, Laboratory of Experimental Hematology, Leiden University Medical Center, Leiden, The Netherlands. ; Olde Wolbers J

Subjects: Graft vs Tumor Effect* ; Stem Cell Transplantation*; Antigen-Presenting Cells/Antigen-Presenting Cells/Antigen-Presenting Cells/*immunology

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2005 Jul 15; Vol. 11 (14), pp. 5310-8.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432

Record details

×
Academic Journal

Strategies to enhance the therapeutic efficacy of autologous hematopoietic stem cell transplantation by posttransplantation adoptive transfer of T cells with engineered graft-versus-tumor activity.

  • Authors : Jensen M; Cancer Immunotherapeutics Program, City of Hope National Medical Center/Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA 91010, USA.

Subjects: Graft vs Tumor Effect*; Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/*methods ; Immunotherapy, Adoptive/Immunotherapy, Adoptive/Immunotherapy, Adoptive/*methods

  • Source: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2005 Feb; Vol. 11 (2 Suppl 2), pp. 34-9.Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma.

  • Authors : Kröger N; Bone Marrow Transplantation and Department of Clinical Chemistry, University Hospital Hamburg-Eppendorf, and A. K. St. Georg, Hamburg, Germany. ; Krüger W

Subjects: Graft vs Tumor Effect*; Immunotherapy, Adoptive/Immunotherapy, Adoptive/Immunotherapy, Adoptive/*methods ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*therapy

  • Source: British journal of haematology [Br J Haematol] 2001 Feb; Vol. 112 (2), pp. 421-3.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print Cited Medium: Print ISSN: 0007-1048 (Print)

Record details

×
Academic Journal

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.

  • Authors : Champlin R; Department of Blood and Marrow Transplantation, University of Texas-MD Anderson Cancer Center, Houston 77030, USA. ; Khouri I

Subjects: Graft vs Tumor Effect*; Bone Marrow Transplantation/Bone Marrow Transplantation/Bone Marrow Transplantation/*methods ; Immunotherapy, Adoptive/Immunotherapy, Adoptive/Immunotherapy, Adoptive/*methods

  • Source: British journal of haematology [Br J Haematol] 2000 Oct; Vol. 111 (1), pp. 18-29.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print Cited Medium: Print ISSN: 0007-1048 (Print)

Record details

×
Academic Journal

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy.

  • Authors : Champlin R; Department of Blood and Marrow Transplantation, University of Texas M.D. Anderson Cancer Center, Houston, USA. ; Khouri I

Subjects: Graft vs Tumor Effect* ; Hematopoietic Stem Cell Transplantation* ; Immunotherapy, Adoptive*

  • Source: Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 1999 Oct; Vol. 13 (5), pp. 1041-57, vii-viii.Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Sialoadhesin-positive host macrophages play an essential role in graft-versus-leukemia reactivity in mice.

  • Authors : Müerköster S; Division of Cellular Immunology, Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany.; Rocha M

Subjects: Graft vs Tumor Effect* ; Immunotherapy, Adoptive*; Lymphoma, T-Cell/Lymphoma, T-Cell/Lymphoma, T-Cell/*therapy

  • Source: Blood [Blood] 1999 Jun 15; Vol. 93 (12), pp. 4375-86.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Print ISSN: 0006-4971 (Print)

Record details

×
Academic Journal

Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.

  • Authors : Mutis T; Department of Immunohematology and Blood Bank, Leiden University Medical Center, Leiden, The Netherlands. ; Verdijk R

Subjects: Graft vs Tumor Effect* ; Immunotherapy, Adoptive* ; Salvage Therapy*

  • Source: Blood [Blood] 1999 Apr 01; Vol. 93 (7), pp. 2336-41.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Print ISSN: 0006-4971 (Print)

Record details

×
  • 1-10 of  49 results for ""Graft vs Tumor Effect""